查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435594

2024 年移植诊断全球市场报告

Transplant Diagnostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

移植诊断的市场规模预计在未来几年将显着成长。预计到 2028 年将以 6.3% 的复合年增长率 (CAGR) 增长至 25.7 亿美元。预测期内的预期增长可归因于以患者为中心的方法、监管调整、活体供体移植的增加、个人化移植医学以及移植手术的整体增长。预测期内预计的主要趋势包括教育和意识计划、市场扩大策略、监管指南的演变、免疫抑制疗法的优化以及生物标记的开发。

急性疾病发生率的增加导致器官衰竭率上升，导致对移植手术的需求增加，进而推动移植诊断市场的发展。器官移植是一个复杂的过程，其成功取决于供体器官与受体身体系统的兼容性。进行诊断测试以评估器官移植的成功机会。据负责监督美国器官移植的非营利组织联合器官共享网络称，2021 年的器官移植数量创历史新高。其中，2021年共实施肾臟移植24,669例、肝臟移植9,236例、心臟移植3817例。诊断测试需求的激增是移植诊断市场的关键驱动力。

器官移植的日益普及预计将推动移植诊断市场的成长。器官移植涉及切除从供体移植到受体的器官、组织或细胞，在改善结果和适宜性评估方面发挥重要作用。移植诊断对于移植前捐赠者合格筛检、识别移植后併发症和监测抗生素疗效至关重要。例如，截至2022年1月，联合器官共用网报道称，2021年美国器官移植数量达到41354例，与前一年同期比较增长5.9%，器官移植数量首次突破4万例。时间到了，我举报了。因此，器官移植数量的增加是移植诊断市场的主要驱动因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球移植诊断市场，按类型、实际和预测细分，2018-2023、2023-2028、2033
  • 试剂及耗材
  • 装置
  • 软体和服务
  • 全球移植诊断市场，依移植类型细分、实际与预测，2018-2023、2023-2028、2033
  • 固体器官
  • 干细胞
  • 全球移植诊断市场，依器官细分、实际及预测，2018-2023、2023-2028、2033
  • 肾
  • 肝
  • 心
  • 肺
  • 胰臟
  • 全球移植诊断市场，依技术细分、实际及预测，2018-2023、2023-2028、2033
  • 非分子测定
  • 分子测定
  • 全球移植诊断市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院及移植中心
  • 研究与移植中心
  • 商业服务供应商

第 7 章 区域与国家分析

  • 全球移植诊断市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球移植诊断市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 移植诊断市场竞争格局
  • 移植诊断市场公司概况
    • F. Hoffmann La-Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories Inc.
    • Becton-Dickinson and Company
    • Hologic Inc.

第31章 其他大型创新公司

  • Illumina Inc.
  • BioMerieus SA
  • Biomerieux SA
  • Grafton Companies
  • Bio-rad Laboratories Inc.
  • Sigma-Aldrich Corporation
  • Qiagen NV
  • Immucor Transplant Diagnostics Inc.
  • Immucor Inc.
  • Luminex Corporation
  • Affymetrix Inc.
  • CareDx Company
  • One Lambda Inc.
  • Eurobio Scientific Group
  • Gendx BV

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r15303

Transplant diagnostics encompass tests performed prior to the transplantation of a donor organ to the recipient patient. In the context of organ transplantation and hematopoietic stem cell transplantation, transplantation diagnostics primarily focus on histocompatibility and immunogenetics.

The primary categories within the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostics instruments are specifically designed products aimed at enhancing the speed and quality of transplant diagnostics. Employing non-molecular assay and molecular assay technologies, transplant diagnostics cover various organs such as kidneys, liver, heart, lungs, and pancreas. The transplant types involved are solid organ and stem cells, with end-users including hospitals and transplant centers, research laboratories and transplant centers, as well as commercial service providers.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transplant diagnostics market size has grown rapidly in recent years. It will grow from $1.82 billion in 2023 to $2.01 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed in the historical period can be ascribed to the advancement of HLA typing, the expansion of organ transplantations, progress in immunosuppressive therapy, the introduction of cross-matching techniques, and the standardization of regulatory measures.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth in the forecast period can be credited to patient-centric approaches, regulatory adaptations, an increase in living donor transplants, personalized transplant medicine, and the overall growth in transplant procedures. Major trends expected in the forecast period include education and awareness programs, strategies for market expansion, the evolution of regulatory guidelines, optimization of immunosuppressive therapy, and the development of biomarkers.

The increasing incidence of acute diseases is contributing to a rise in organ failure rates, leading to a heightened demand for transplant procedures and subsequently propelling the transplant diagnostics market. Organ transplantations are intricate processes, and the success of such procedures hinges on the compatibility of the donor's organ with the recipient's body system. To assess the potential success of organ transplants, diagnostic tests are conducted. According to the United Network for Organ Sharing, a non-profit organization overseeing organ transplantation in the US, the year 2021 witnessed a record-setting number of organ transplants. Notably, 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplant procedures were conducted in 2021. This surge in demand for diagnostic tests is a significant driver for the transplant diagnostics market.

The increasing prevalence of organ transplants is anticipated to fuel the transplant diagnostics market's growth. Organ transplantation, involving the removal of organs, tissues, or cells from a donor to be transplanted into a recipient, plays a critical role in improving outcomes and compatibility assessment. Transplant diagnostics are essential for pre-transplant donor eligibility screening, identification of post-transplant complications, and monitoring the effectiveness of antimicrobial agents. For example, as of January 2022, the United Network for Organ Sharing reported that the number of organ transplants in the United States reached 41,354 in 2021, marking a 5.9% increase from the previous year and surpassing the 40,000 milestone for the first time. Consequently, the growing number of organ transplants is a key driver for the transplant diagnostics market.

The substantial gap between organ donation and the demand for organ transplantation poses a challenge to the transplant diagnostics market's growth. The insufficient number of organ donors falls significantly short of meeting the increasing demand for organ transplants. As of 2021, the Health Resources and Services Administration reported that 106,090 people were on the waiting list for organ donations. This widening gap between organ supply and demand contributes to a deficit of organ donors, limiting the requirement for transplant diagnostic tests and devices and consequently impeding market growth.

Prominent companies in the transplant diagnostics market are strategically introducing advanced services to enhance their market profitability. Advanced transplant diagnostic services entail the utilization of innovative diagnostic tools and technologies to enhance the precision and efficiency of pre-transplant and post-transplant testing procedures. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, unveiled Quest Advanced Specialized Transplant Services, an extensive array of cutting-edge diagnostics and support services designed to enhance access to laboratory tests for solid organ, human cell, and tissue transplants. This comprehensive offering includes over 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results integrated into the physician's electronic medical record (EMR), and 24/7 support services, including medical consultation to ensure appropriate test selection and result interpretation impacting patient care. The new services expand upon Quest's previous transplant testing offerings with added capabilities, including patient-customized information packets and expedited testing for patients visiting Quest's 2,100 patient service centers, with some test results obtainable within 8-24 hours.

Companies are increasingly adopting Next Generation Sequencing (NGS) for donor-recipient matching tests. NGS technology facilitates the sequencing of an entire human genome, enabling the matching of genes between donors and recipients to determine the suitability for organ transplantation. Virtually all current transplant diagnostic tests and devices leverage NGS technology to inform decisions related to organ transplantation. Castle Biosciences, for instance, introduced the Decision Dx-CMSeq Test, utilizing NGS (Next Generation Sequencing) to identify somatic mutations in genes.

In August 2022, Eurobio Scientific, a biotechnology company based in France, completed the acquisition of GenDx for $134.3 million (€135 million). This strategic move is anticipated to bolster Eurobio's research efforts in the field of transplantation. GenDx is a molecular diagnostics startup headquartered in the Netherlands.

Major companies operating in the transplant diagnostics market report are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive PLC, BioGenuix, Pure Transplant Solutions

North America was the largest region in the transplant diagnostics market in 2023. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Reagent & Consumables; Instrument; Software & Services
  • 2) By Transplant Type: Solid Organ; Stem Cell
  • 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
  • 4) By Technology: Non Molecular Assay; Molecular Assay
  • 5) By End User: Hospitals and Transplant Centers; Research Laboratories & Transplant Centers; Commercial Service Providers
  • Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transplant Diagnostics Market Characteristics

3. Transplant Diagnostics Market Trends And Strategies

4. Transplant Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Transplant Diagnostics Market Size and Growth

  • 5.1. Global Transplant Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Transplant Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Transplant Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Transplant Diagnostics Market Segmentation

  • 6.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagent & Consumables
  • Instrument
  • Software & Services
  • 6.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solid Organ
  • Stem Cell
  • 6.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • 6.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Non Molecular Assay
  • Molecular Assay
  • 6.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals and Transplant Centers
  • Research Laboratories & Transplant Centers
  • Commercial Service Providers

7. Transplant Diagnostics Market Regional And Country Analysis

  • 7.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Transplant Diagnostics Market

  • 8.1. Asia-Pacific Transplant Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Transplant Diagnostics Market

  • 9.1. China Transplant Diagnostics Market Overview
  • 9.2. China Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Transplant Diagnostics Market

  • 10.1. India Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Transplant Diagnostics Market

  • 11.1. Japan Transplant Diagnostics Market Overview
  • 11.2. Japan Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Transplant Diagnostics Market

  • 12.1. Australia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Transplant Diagnostics Market

  • 13.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Transplant Diagnostics Market

  • 14.1. South Korea Transplant Diagnostics Market Overview
  • 14.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Transplant Diagnostics Market

  • 15.1. Western Europe Transplant Diagnostics Market Overview
  • 15.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Transplant Diagnostics Market

  • 16.1. UK Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Transplant Diagnostics Market

  • 17.1. Germany Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Transplant Diagnostics Market

  • 18.1. France Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Transplant Diagnostics Market

  • 19.1. Italy Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Transplant Diagnostics Market

  • 20.1. Spain Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Transplant Diagnostics Market

  • 21.1. Eastern Europe Transplant Diagnostics Market Overview
  • 21.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Transplant Diagnostics Market

  • 22.1. Russia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Transplant Diagnostics Market

  • 23.1. North America Transplant Diagnostics Market Overview
  • 23.2. North America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Transplant Diagnostics Market

  • 24.1. USA Transplant Diagnostics Market Overview
  • 24.2. USA Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Transplant Diagnostics Market

  • 25.1. Canada Transplant Diagnostics Market Overview
  • 25.2. Canada Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Transplant Diagnostics Market

  • 26.1. South America Transplant Diagnostics Market Overview
  • 26.2. South America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Transplant Diagnostics Market

  • 27.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Transplant Diagnostics Market

  • 28.1. Middle East Transplant Diagnostics Market Overview
  • 28.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Transplant Diagnostics Market

  • 29.1. Africa Transplant Diagnostics Market Overview
  • 29.2. Africa Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Transplant Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Transplant Diagnostics Market Competitive Landscape
  • 30.2. Transplant Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann La-Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton-Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hologic Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Transplant Diagnostics Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. BioMerieus S.A
  • 31.3. Biomerieux SA
  • 31.4. Grafton Companies
  • 31.5. Bio-rad Laboratories Inc.
  • 31.6. Sigma-Aldrich Corporation
  • 31.7. Qiagen N.V.
  • 31.8. Immucor Transplant Diagnostics Inc.
  • 31.9. Immucor Inc.
  • 31.10. Luminex Corporation
  • 31.11. Affymetrix Inc.
  • 31.12. CareDx Company
  • 31.13. One Lambda Inc.
  • 31.14. Eurobio Scientific Group
  • 31.15. Gendx BV

32. Global Transplant Diagnostics Market Competitive Benchmarking

33. Global Transplant Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Transplant Diagnostics Market

35. Transplant Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Transplant Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Transplant Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Transplant Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer